Related Experiment Video
Updated: Apr 29, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Challenges in vaccination of neonates, infants and young children
1Rochester General Hospital Research Institute, Rochester, NY 14621, United States of America.
Insights
Pediatric vaccination requires better understanding of infant immune responses to improve vaccine efficacy. Research focuses on antibody, B-cell, T-cell, and APC functions for stronger, longer-lasting immunity.
Area of Science:
- Immunology
- Pediatrics
- Vaccinology
Background:
- Neonates, infants, and young children receive multiple vaccine doses to prevent infections.
- Despite high vaccine compliance, outbreaks of vaccine-preventable diseases persist globally.
- Current pediatric vaccination strategies may require optimization for more robust and prolonged immunity.
Purpose of the Study:
- To enhance understanding of pediatric immune responses to vaccine antigens.
- To explore mechanisms for achieving improved and sustained immunity in young children.
- To inform strategies for potentially reducing the number of primary and booster vaccinations.
Main Methods:
- Review of recent research on infant and young child immunity following routine vaccinations.
- Analysis of systemic antibody responses.
- Evaluation of memory B-cell generation.
- Assessment of CD4 T-cell responses.
- Investigation of antigen-presenting cell (APC) function.
Main Results:
- Data indicate a need for improved understanding of pediatric immune responses to vaccines.
- Specific immune parameters like antibody levels, memory B-cells, CD4 T-cells, and APC function are crucial for vaccine effectiveness.
- Variability in immune responses highlights potential targets for enhancement.
Conclusions:
- Further research into pediatric immune responses is essential for optimizing vaccine strategies.
- Targeting specific immune mechanisms could lead to more effective and potentially less frequent vaccination schedules.
- Improving vaccine-induced immunity in infants and children is critical for global public health.
Abstract:
All neonates, infants and young children receive multiple priming doses and booster vaccinations in the 1st and 2nd year of life to prevent infections by viral and bacterial pathogens. Despite high vaccine compliance, outbreaks of vaccine-preventable infections are occurring worldwide. These data strongly argue for an improved understanding of the immune responses of neonates, infants and young children to vaccine antigens and further study of the exploitable mechanisms to achieve more robust and prolonged immunity with fewer primary and booster vaccinations in the pediatric population. This review will focus on our recent work involving infant and young child immunity following routine recommended vaccinations. The discussion will address vaccine responses with respect to four areas: (1) systemic antibody responses, (2) memory B-cell generation, (3) CD4 T-cell responses, and (4) APC function.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Vaccinations
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

